Company news
OptiBiotix Health PLC news in 2022
OptiBiotix Health PLC's news releases, calls and decks from 2022, newest first.
Issue of Equity - Subscription
December 5, 2022
Launch of GoFigure products on Tmall China
November 1, 2022
Approval of GoFigure products
October 24, 2022
New health claims for SlimBiome in Australia
October 17, 2022
Launch of novel prebiotic in Europe and Africa
September 26, 2022
Launch of GoFigure range with Apollo Hospitals
September 20, 2022
New commercialisation partner in Asia Pacific
September 14, 2022
Second Price Monitoring Extn
August 24, 2022
Price Monitoring Extension
August 24, 2022
Commercial and scientific update
July 20, 2022
Joint development agreement signed with Firmenich
July 11, 2022
Director Appointment and Director Dealing
July 1, 2022
ProBiotix Health - Appointment of CEO
June 20, 2022
Admission of ProBiotix Health plc to AQSE
March 31, 2022
Intention to list ProBiotix Health on AQSE
March 17, 2022
Exercise of warrants
March 9, 2022
Commercial Appointments
March 1, 2022
Trading Update
February 28, 2022
Commercial and strategy update
February 9, 2022
Consumer study of LPLDL in Cholbiome products
February 1, 2022
Exercise of Warrants
January 27, 2022
Publication of third human study on LPLDL
January 18, 2022
Issue of options
January 7, 2022
OptiBiotix obtains BRC accreditation
January 5, 2022